Scapular Muscle Activation and Shoulder Performance in Migraine
INVESTIGATION OF SCAPULAR MUSCLE ACTIVATION AND SHOULDER PERFORMANCE IN INDIVIDUALS WITH MIGRAINE
1 other identifier
observational
50
1 country
1
Brief Summary
Migraine is a significant health problem due to its high prevalence and substantial contribution to disability. Individuals with migraine have been reported to exhibit myofascial trigger points, increased pain sensitivity, and altered muscle activation patterns, particularly in the trapezius muscles. As the upper and middle trapezius muscles play critical roles in scapular stability and movement, alterations in these muscles may affect scapular orientation and upper extremity function. However, studies investigating the relationship between trapezius muscle activation, scapular orientation, and upper extremity performance in individuals with migraine are limited. Therefore, this study aimed to compare trapezius muscle activation, scapular orientation, and upper extremity performance between individuals with and without migraine. We hypothesized that individuals with migraine would exhibit altered upper and middle trapezius muscle activation, impaired scapular orientation, and reduced upper extremity performance compared with healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
June 15, 2026
CompletedFirst Posted
Study publicly available on registry
June 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2026
CompletedJune 18, 2026
June 1, 2026
3 months
June 15, 2026
June 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Trapezius muscle activity
Upper and middle trapezius muscle activations will be assessed on the dominant side using surface electromyography (sEMG). Following skin preparation, EMG sensors will be placed over the upper and middle trapezius muscles according to the recommendations of the Surface Electromyography for the Non-Invasive Assessment of Muscles (SENIAM). Resting muscle activity will be recorded prior to measurements to ensure signal quality. Muscle activations will first be recorded during maximal voluntary isometric contraction (MVIC) and subsequently during arm elevation in the scapular plane. EMG data will be analyzed using EMGworks software; signals will be filtered, processed using the root mean square (RMS) method, and normalized to each participant's MVIC values, expressed as %MVIC. Additionally, upper trapezius/middle trapezius activation ratios will be calculated, and muscle activation levels will be categorized according to predefined threshold values.
Single assessment at baseline
Secondary Outcomes (3)
Scapular rotation
Single assessment at baseline
Pain
Single assessment at baseline
Upper extremity performance
Single assessment at baseline
Study Arms (2)
Migraine
Control
Eligibility Criteria
Adults diagnosed with migraine according to the ICHD-3 criteria
You may qualify if:
- Aged 18-55 years
- Diagnosed with migraine by a neurologist according to the ICHD-3 criteria
- Experiencing at least 3 migraine attacks per month
- Willing to participate and provide written informed consent
You may not qualify if:
- Presence of other types of headache disorders
- History of trauma, fracture, or surgery involving the cranio-cervical region, scapular region, or upper extremity
- Presence of neurological or inflammatory rheumatic diseases
- Presence of psychiatric disorders
- Receiving physiotherapy or rehabilitation for migraine or the cervical, thoracic, or upper extremity regions within the past 6 months
- Cognitive impairment affecting the understanding of test instructions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Yıldırım Beyazıt University
Ankara, Çubuk, 06760, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 18, 2026
Study Start
April 1, 2026
Primary Completion
July 1, 2026
Study Completion
July 15, 2026
Last Updated
June 18, 2026
Record last verified: 2026-06